Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This made my day a little bit better
"Of course, there will be those who were hoping for a 62.1% increase in revenue and gross profit up 45.7%."
lol..:)
Nothing has changed.
Some people need to calm down. We will hear something soon.
Thank you Mr. Tomas
Yep.
USRM$
"It has no real value at the moment"
lol
lol..:)
USRM$
Lets have a good day tomorrow.
Yep that's one example.
GLTY
Try to keep fear in its place. If I let fear determine my decisions in the stock market I would never have any success. It takes some balls to stay in it. No regrets.
I hope not.
There is only one way to go.
Considering phase 2/3 results RMAT will happen otherwise the Fed could be seen as undermining the 21st Century Cures Act and the purpose of Fast Track trials.
Denial would go against Gottlieb and the senate majority.
The FDA received the additional information otherwise they would not have reinstated Marvel.
This is how I understand it to be.
Repost of CEO blog
Posted by U.S. Stem Cell, Inc
Dear Shareholders and Friends,
U.S. Stem Cell, Inc. has seen many exciting accomplishments in April. We have curated new partnerships, finalized investments, and received updates on our RMAT designation from the Food and Drug Administration (FDA).
We have recently partnered with Advanced Stem Cell RX in a strategic alliance to commercialize our proprietary applications and protocols. Advanced Stem Cell RX will aid us in implementing U.S. Stem Cell, Inc. programs into qualified practices and clinics in over 20 different states. They will be utilizing our technology to treat patients suffering from degenerative disorders.
On January 27, 2017, U.S. Stem Cell, Inc. applied for the FDA’s new Regenerative Medicine Advanced Therapy (RMAT) designation for the MyoCell™ product as part of the MARVEL trial. After application, the FDA is given 60 days to review it or request additional information. In late March, the FDA requested additional information in order to reinstate our IND (MARVEL trial)—which has been reinstated to active status. Please note that each time more information is requested, the 60-day timeline resets and the FDA is afforded additional regulatory processing time. Currently, U.S. Stem Cell, Inc. is operating within the regulatory timeline and is actively working with the FDA to quickly and effectively fulfill requests for supplementary materials. We will continue to keep our base informed on any FDA communications that affect this timeline.
For example if "late March" actually meant 3/31 then today would be 60 days.
I expect to know something this week.
Stay strong.
Nope.
USRM$
Not bad at all. I'm holding until buy out:)
Lol. Is that all you want? I want much more.
Absolutely. I am right there with you.
We are early birds.
USRM$
Shadow the cat says follow the money.
I don't think you have any...left to bet. You lost them a long time ago.
Been here quite a while :)
Patience in this case is a virtue that some people don't understand. The s/p base has been formed and held by longs. I have added my fair share since the beginning of the year. I am ready for a decision whether it be next week or the week after. I can't imagine a scenario where we would not get RMAT designation. I think the real question is at what level?
The U.S. needs to be a leader in stem cell tech - something congress and Gottlieb understand all too well.
Very excited and optimistic.
USRM$
60 hrs week. Respect to you. Been there myself its not easy.
GLTU.
USRM long and strong.
To the MOON Kramden1.
We are on the same side. I am just a bit tense right now. I wish you and everyone else only the best. I hope we can all celebrate together soon.
USRM$
You have your opinion. I have mine. We shall see what happens.
Could be. But if 60 days were some unwritten rule that would give investors an unfair advantage. It would be like having insider information regarding timing your investment. I stand by my hypothesis.
It is my belief that USRM already knows the FDA decision.
I don't think the FDA needed the full 60 days to process the additional information requested.
If my hypothesis is correct, why is USRM holding back?
Somethings got to break soon.
Looks like it.
I'm not worried.
Looking forward to tomorrow :)
Lets go baby.
Shadow (my cat) says good morning.
Lets go USRM$
USRM$
:)
"Just saying, they are buying higher & eventually the flip goes away"
Exactly.
That is why I don't flip a stock that I expect is going to run hard.
Living off the daily is a mistake with this one. Its when greed overcomes logic.
Beer money?
I think that would be unwise considering the Fed's timeline.
I don't like bragging either. We are not here for the flippers. They can flip off.
Hey BR.
Green week as in 5 day average.
We will be up for the week without question.
Check back with me on Friday :)
I feel it too.
Did not see it.
Truth be told, surveillance of L2 is of little consequence to me at this point in the game.
We are in the ninth inning.
I am all in now because I know what's coming.
We are in this together.
Picked up another 200k yesterday AM.
As I said yesterday, it will be a green$ week.
More green.
Lets go.
RMAT + Buyout = $$$
It's time. Green week coming up. Get ready.
USRM$
Yes we do :)
Been here since before .02
Where we meet?
I'll buy the 1st round..lol